HTLV-1 Tax protein recruitment into IKKε and TBK1 kinase complexes enhances IFN-I expression

Virology

Volumn 476, Issue , 2015, Pages 92-99

  Diani, Erica ^a   Avesani, Francesca ^a   Bergamo, Elisa ^a   Cremonese, Giorgia ^a   Bertazzoni, Umberto ^a   Romanelli, Maria Grazia ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Cell signaling; HTLV; IFN; IKK ; IRF3; Tax; TBK1

Indexed keywords

I KAPPA B KINASE; I KAPPA B KINASE EPSILON; INTERFERON; TANK BINDING KINASE 1; TAX PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG; BETA INTERFERON; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1; TBK1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; WESTERN BLOTTING; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; METABOLISM; TRANSCRIPTION INITIATION; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; I-KAPPA B KINASE; INTERFERON-BETA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; TNF RECEPTOR-ASSOCIATED FACTOR 3; TRANSCRIPTIONAL ACTIVATION;

EID: 84919372010     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.12.005     Document Type: Article

References (82)

1. Araujo A., Hall W.W. Human T-lymphotropic virus type II and neurological disease. Ann. Neurol. 2004, 56:10-19. 10.1002/ana.20126.
2. Avesani F., Romanelli M.G., Turci M., Di Gennaro G., Sampaio C., Bidoia C., Bertazzoni U., Bex F. Association of HTLV Tax proteins with TAK1-binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-κB activation. Virology 2010, 408:39-48. 10.1016/j.virol.2010.08.023.
3. Azran I., Schavinsky-Khrapunsky Y., Aboud M. Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology 2004, 1:20. 10.1186/1742-4690-1-20.
4. Barbeau B., Peloponese J.-M., Mesnard J.-M. Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front. Microbiol 2013, 4:226. 10.3389/fmicb.2013.00226.
5. Barbie D.A., Tamayo P., Boehm J.S., Kim S.Y., Moody S.E., Dunn I.F., Schinzel A.C., Sandy P., Meylan E., Scholl C., Fröhling S., Chan E.M., Sos M.L., Michel K., Mermel C., Silver S.J., Weir B.A., Reiling J.H., Sheng Q., Gupta P.B., Wadlow R.C., Le H., Hoersch S., Wittner B.S., Ramaswamy S., Livingston D.M., Sabatini D.M., Meyerson M., Thomas R.K., Lander E.S., Mesirov J.P., Root D.E., Gilliland D.G., Jacks T., Hahn W.C. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-112. 10.1038/nature08460.
6. Bertazzoni U., Turci M., Avesani F., Di Gennaro G., Bidoia C., Romanelli M.G. Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences. Viruses 2011, 3:541-560. 10.3390/v3050541.
7. Bex F., McDowall A., Burny A., Gaynor R. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J. Virol. 1997, 71:3484-3497.
8. Biswas H.H., Kaidarova Z., Garratty G., Gibble J.W., Newman B.H., Smith J.W., Ziman A., Fridey J.L., Sacher R.A., Murphy E.L. Increased all-cause and cancer mortality in HTLV-II infection. J. Acquir. Immune Defic. Syndr. 2010, 54:290-296. 10.1097/QAI.0b013e3181cc5481.
9. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8:911-922. 10.1038/nri2436.
10. Breiman A., Grandvaux N., Lin R., Ottone C., Akira S., Yoneyama M., Fujita T., Hiscott J., Meurs E.F. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J. Virol. 2005, 79:3969-3978. 10.1128/JVI.79.7.3969-3978.2005.
11. Buss H., Dörrie A., Schmitz M.L., Hoffmann E., Resch K., Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1). J. Biol. Chem. 2004, 279:55633-55643. 10.1074/jbc.M409825200.
12. Cavallari I., Rende F., Bender C., Romanelli M.G., D'Agostino D.M., Ciminale V. Fine tuning of the temporal expression of HTLV-1 and HTLV-2. Front. Microbiol 2013, 4:235. 10.3389/fmicb.2013.00235.
13. Charoenthongtrakul S., Zhou Q., Shembade N., Harhaj N.S., Harhaj E.W. Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1. J. Virol. 2011, 85:6955-6962. 10.1128/JVI.00007-11.
14. Charoenthongtrakul S., Gao L., Parvatiyar K., Lee D., Harhaj E.W. RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS One 2013, 8:e53717. 10.1371/journal.pone.0053717.
15. Chau T.-L., Gioia R., Gatot J.-S., Patrascu F., Carpentier I., Chapelle J.-P., O'Neill L., Beyaert R., Piette J., Chariot A. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?. Trends Biochem. Sci. 2008, 33:171-180. 10.1016/j.tibs.2008.01.002.
16. Chen H., Jiang Z. The essential adaptors of innate immune signaling. Protein Cell 2013, 4:27-39. 10.1007/s13238-012-2063-0.
17. Chu Z.L., DiDonato J.A., Hawiger J., Ballard D.W. The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IkappaB kinases containing IKKalpha and IKKbeta. J. Biol. Chem. 1998, 273:15891-15894.
18. Ciminale V., Rende F., Bertazzoni U., Romanelli M.G. HTLV-1 and HTLV-2: highly similar viruses and distinct oncogenic properties. Front. Microbiol. 2014, 5:398. 10.3389/fmicb.2014.00398.
19. Clark K., Plater L., Peggie M., Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 2009, 284:14136-14146. 10.1074/jbc.M109.000414.
20. Clark K., Peggie M., Plater L., Sorcek R.J., Young E.R.R., Madwed J.B., Hough J., McIver E.G., Cohen P. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 2011, 434:93-104. 10.1042/BJ20101701.
21. Clément J.-F., Meloche S., Servant M.J. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 2008, 18:889-899. 10.1038/cr.2008.273.
22. Cui J., Li Y., Zhu L., Liu D., Songyang Z., Wang H.Y., Wang R.-F. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat. Immunol. 2012, 13:387-395. 10.1038/ni.2239.
23. Currer R., Van Duyne R., Jaworski E., Guendel I., Sampey G., Das R., Narayanan A., Kashanchi F. HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways. Front. Microbiol 2012, 3:406. 10.3389/fmicb.2012.00406.
24. Ferronato S., Gomez-Lira M., Menegazzi M., Diani E., Olivato S., Sartori M., Scuro A., Malerba G., Pignatti P.F., Romanelli M.G., Mazzucco S. Polymorphism-2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients. J. Hum. Genet. 2013, 58:812-814. 10.1038/jhg.2013.98.
25. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.-M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496. 10.1038/ni921.
26. Forlani G., Abdallah R., Accolla R.S., Tosi G. The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators. Front. Microbiol 2013, 4:234. 10.3389/fmicb.2013.00234.
27. Gatot J.-S., Gioia R., Chau T.-L., Patrascu F., Warnier M., Close P., Chapelle J.-P., Muraille E., Brown K., Siebenlist U., Piette J., Dejardin E., Chariot A. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J. Biol. Chem. 2007, 282:31131-31146. 10.1074/jbc.M701690200.
28. Gessain A., Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol 2012, 3:388. 10.3389/fmicb.2012.00388.
29. Gessain A., Mahieux R. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. Rev. Neurol. (Paris) 2012, 168:257-269. 10.1016/j.neurol.2011.12.006.
30. Goncalves A., Bürckstümmer T., Dixit E., Scheicher R., Górna M.W., Karayel E., Sugar C., Stukalov A., Berg T., Kralovics R., Planyavsky M., Bennett K.L., Colinge J., Superti-Furga G. Functional dissection of the TBK1 molecular network. PLoS One 2011, 6:e23971. 10.1371/journal.pone.0023971.
31. Gu L., Fullam A., Brennan R., Schröder M. Human DEAD box helicase 3 couples IκB kinase ε to interferon regulatory factor 3 activation. Mol. Cell. Biol. 2013, 33:2004-2015. 10.1128/MCB.01603-12.
32. Häcker H., Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006 2006, (re13). 10.1126/stke.3572006re13.
33. Häcker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.-C., Wang G.G., Kamps M.P., Raz E., Wagner H., Häcker G., Mann M., Karin M. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006, 439:204-207. 10.1038/nature04369.
34. Häcker H., Tseng P.-H., Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 2011, 11:457-468. 10.1038/nri2998.
35. Harhaj E.W., Sun S.C. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J. Biol. Chem. 1999, 274:22911-22914.
36. He J.Q., Oganesyan G., Saha S.K., Zarnegar B., Cheng G. TRAF3 and its biological function. Adv. Exp. Med. Biol. 2007, 597:48-59. 10.1007/978-0-387-70630-6_4.
37. Helgason E., Phung Q.T., Dueber E.C. Recent insights into the complexity of Tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1. FEBS Lett. 2013, 587:1230-1237. 10.1016/j.febslet.2013.01.059.
38. Imai M., Higuchi M., Kawamura H., Yoshita M., Takahashi M., Oie M., Matsuki H., Tanaka Y., Aoyagi Y., Fujii M. Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells. Virus Genes 2013, 46:39-46. 10.1007/s11262-012-0831-9.
39. Jin D.Y., Giordano V., Kibler K.V, Nakano H., Jeang K.T. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J. Biol. Chem. 1999, 274:17402-17405.
40. Kang H.-R., Cheong W.-C., Park J.-E., Ryu S., Cho H.-J., Youn H., Ahn J.-H., Song M.J. Murine gammaherpesvirus 68 encoding open reading frame 11 targets TANK binding kinase 1 to negatively regulate the host type I interferon response. J. Virol. 2014, 88:6832-6846. 10.1128/JVI.03460-13.
41. Kannian P., Green P.L. Human T lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis. Viruses 2010, 2:2037-2077. 10.3390/v2092037.
42. Kayagaki N., Phung Q., Chan S., Chaudhari R., Quan C., O'Rourke K.M., Eby M., Pietras E., Cheng G., Bazan J.F., Zhang Z., Arnott D., Dixit V.M. DUBA: a deubiquitinase that regulates type I interferon production. Science 2007, 318:1628-1632. 10.1126/science.1145918.
43. Kinpara S., Hasegawa A., Utsunomiya A., Nishitsuji H., Furukawa H., Masuda T., Kannagi M. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon. J. Virol. 2009, 83:5101-5108. 10.1128/JVI.02564-08.
44. Lai M.-C., Lee Y.-H.W., Tarn W.-Y. The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control. Mol. Biol. Cell 2008, 19:3847-3858. 10.1091/mbc.E07-12-1264.
45. Lamsoul I., Lodewick J., Lebrun S., Brasseur R., Burny A., Gaynor R.B., Bex F. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol. Cell. Biol. 2005, 25:10391-10406. 10.1128/MCB.25.23.10391-10406.2005.
46. Li S., Zheng H., Mao A.-P., Zhong B., Li Y., Liu Y., Gao Y., Ran Y., Tien P., Shu H.-B. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J. Biol. Chem. 2010, 285:4291-4297. 10.1074/jbc.M109.074971.
47. Li J., Huang J., Jeong J.-H., Park S.-J., Wei R., Peng J., Luo Z., Chen Y.T., Feng Y., Luo J.-L. Selective TBK1/IKKi dual inhibitors with anticancer potency. Int. J. Cancer 2014, 134:1972-1980. 10.1002/ijc.28507.
48. Lin R., Heylbroeck C., Pitha P.M., Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 1998, 18:2986-2996.
49. Lu L.L., Puri M., Horvath C.M., Sen G.C. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J. Biol. Chem. 2008, 283:14269-14276. 10.1074/jbc.M710089200.
50. Matsuoka M., Jeang K.-T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7:270-280. 10.1038/nrc2111.
51. Mattioli I., Geng H., Sebald A., Hodel M., Bucher C., Kracht M., Schmitz M.L. Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J. Biol. Chem. 2006, 281:6175-6183. 10.1074/jbc.M508045200.
52. Ohsugi T. A transgenic mouse model of human T cell leukemia virus type 1-associated diseases. Front. Microbiol 2013, 4:49. 10.3389/fmicb.2013.00049.
53. Olière S., Hernandez E., Lézin A., Arguello M., Douville R., Nguyen T.L.-A., Olindo S., Panelatti G., Kazanji M., Wilkinson P., Sékaly R.-P., Césaire R., Hiscott J. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog. 2010, 6:e1001177. 10.1371/journal.ppat.1001177.
54. Parvatiyar K., Barber G.N., Harhaj E.W. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J. Biol. Chem. 2010, 285:14999-15009. 10.1074/jbc.M110.109819.
55. Pilotti E., Bianchi M.V, De Maria A., Bozzano F., Romanelli M.G., Bertazzoni U., Casoli C. HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status. Front. Microbiol 2013, 4:372. 10.3389/fmicb.2013.00372.
56. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89:1-47. 10.1099/vir.0.83391-0.
57. Ren T., Cheng H. Differential transforming activity of the retroviral Tax oncoproteins in human T lymphocytes. Front. Microbiol 2013, 4:287. 10.3389/fmicb.2013.00287.
58. Rende F., Cavallari I., Romanelli M.G., Diani E., Bertazzoni U., Ciminale V. Comparison of the genetic organization, expression strategies and oncogenic potential of HTLV-1 and HTLV-2. Leuk. Res. Treat. 2012, 2012:876153. 10.1155/2012/876153.
59. Romanelli M.G., Diani E., Bergamo E., Casoli C., Ciminale V., Bex F., Bertazzoni U. Highlights on distinctive structural and functional properties of HTLV Tax proteins. Front. Microbiol. 2013, 4:271. 10.3389/fmicb.2013.00271.
60. Roucoux D.F., Murphy E.L. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004, 6:144-154.
61. Sharma S., tenOever B.R., Grandvaux N., Zhou G.-P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151. 10.1126/science.1081315.
62. Sheehy N., Lillis L., Watters K., Lewis M., Gautier V., Hall W. Functional analysis of human T lymphotropic virus type 2 Tax proteins. Retrovirology 2006, 3:20. 10.1186/1742-4690-3-20.
63. Shimada T., Kawai T., Takeda K., Matsumoto M., Inoue J., Tatsumi Y., Kanamaru A., Akira S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int. Immunol. 1999, 11:1357-1362.
64. Shirinian M., Kfoury Y., Dassouki Z., El-Hajj H., Bazarbachi A. Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation. Front. Microbiol 2013, 4:231. 10.3389/fmicb.2013.00231.
65. Smith M.R., Greene W.C. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 1990, 4:1875-1885.
66. Sugata K., Satou Y., Yasunaga J., Hara H., Ohshima K., Utsunomiya A., Mitsuyama M., Matsuoka M. HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood 2012, 119:434-444. 10.1182/blood-2011-05-357459.
67. Suzuki S., Zhou Y., Refaat A., Takasaki I., Koizumi K., Yamaoka S., Tabuchi Y., Saiki I., Sakurai H. Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways. J. Biol. Chem. 2010, 285:4441-4446. 10.1074/jbc.M109.031476.
68. Tosi G., Forlani G., Andresen V., Turci M., Bertazzoni U., Franchini G., Poli G., Accolla R.S. Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication. J. Virol. 2011, 85:10719-10729. 10.1128/JVI.00813-11.
69. Turci M., Lodewick J., Righi P., Polania A., Romanelli M.G., Bex F., Bertazzoni U. HTLV-2B Tax oncoprotein is modified by ubiquitination and sumoylation and displays intracellular localization similar to its homologue HTLV-1 Tax. Virology 2009, 386:6-11. 10.1016/j.virol.2009.01.003.
70. Turci M., Lodewick J., Di Gennaro G., Rinaldi A.S., Marin O., Diani E., Sampaio C., Bex F., Bertazzoni U., Romanelli M.G. Ubiquitination and sumoylation of the HTLV-2 Tax-2B protein regulate its NF-κB activity: a comparative study with the HTLV-1 Tax-1 protein. Retrovirology 2012, 9:102. 10.1186/1742-4690-9-102.
71. Unterholzner L., Sumner R.P., Baran M., Ren H., Mansur D.S., Bourke N.M., Randow F., Smith G.L., Bowie A.G. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog. 2011, 7:e1002247. 10.1371/journal.ppat.1002247.
72. Unterstab G., Ludwig S., Anton A., Planz O., Dauber B., Krappmann D., Heins G., Ehrhardt C., Wolff T Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc. Natl. Acad. Sci. U.S.A 2005, 102:13640-13645. 10.1073/pnas.0502883102.
73. van Zuylen W.J., Doyon P., Clément J.-F., Khan K.A., D'Ambrosio L.M., DÔ F., St-Amant-Verret M., Wissanji T., Emery G., Gingras A.-C., Meloche S., Servant M.J. Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity. PLoS Pathog. 2012, 8:e1002747. 10.1371/journal.ppat.1002747.
74. Verhelst K., Verstrepen L., Carpentier I., Beyaert R. IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer. Biochem. Pharmacol. 2013, 85:873-880. 10.1016/j.bcp.2013.01.007.
75. Wang S., Wang K., Li J., Zheng C. Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. J. Virol. 2013, 87:11851-11860. 10.1128/JVI.01211-13.
76. Wu X., Sun S.-C. Retroviral oncoprotein Tax deregulates NF-kappaB by activating Tak1 and mediating the physical association of Tak1-IKK. EMBO Rep. 2007, 8:510-515. 10.1038/sj.embor.7400931.
77. Xiao G., Harhaj E.W., Sun S.C. Domain-specific interaction with the I kappa B kinase (IKK) regulatory subunit IKK gamma is an essential step in tax-mediated activation of IKK. J. Biol. Chem. 2000, 275:34060-34067. 10.1074/jbc.M002970200.
78. Xiao G., Cvijic M.E., Fong A., Harhaj E.W., Uhlik M.T., Waterfield M., Sun S.C. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 2001, 20:6805-6815. 10.1093/emboj/20.23.6805.
79. Yamagishi M., Watanabe T. Molecular hallmarks of adult T cell leukemia. Front. Microbiol 2012, 3:334. 10.3389/fmicb.2012.00334.
80. Yin M.J., Christerson L.B., Yamamoto Y., Kwak Y.T., Xu S., Mercurio F., Barbosa M., Cobb M.H., Gaynor R.B. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 1998, 93:875-884.
81. Yoneyama M., Suhara W., Fukuhara Y., Sato M., Ozato K., Fujita T. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 1996, 120:160-169.
82. Zhao W. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett. 2013, 587:542-548. 10.1016/j.febslet.2013.01.052.